|
[1]BADIANI RG,BECKER V,PEREZ RM,et al.Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?[J].World J Gastroenterol,2010,16(29):3704-3708.
|
|
[2]MACKIE FD,PEAKMAN M,YUN M,et al.Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus[J].Gastroenterology,1994,106(6):1672-1675.
|
|
[3]ZAREBSKA-MICHALUK DA,LEBENSZTEJN DM,KRYCZKA WM,et al.Extrahepatic manifestations associated with chronic hepatitis C infections in Poland[J].Adv Med Sci,2010,55(1):67-73.
|
|
[4]KERKAR N,CHOUDHURI K,MA Y,et al.Cytochrome P4502D6(193-212):a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J].J Immunol,2003,170(3):1481-1489.
|
|
[5]CONCA P,TARANTINO G.Hepatitis C virus lymphotropism and peculiar immunological phenotype:effects on natural history and antiviral therapy[J].World J Gastroenterol,2009,15(19):2305-2308.
|
|
[6]SANSONNO L,TUUCCI FA,SANSONNO S,et al.B cells and HCV:an infection model of autoimmunity[J].Autoimmun Rev,2009,9(2):93-94.
|
|
[7]CLAASSEN MA,de KNEGT RJ,TILANUS HW,et al.Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J].J Hepatol,2010,52(3):315-321.
|
|
[8]FABRIS P,BETTRELE C,GREGGIO NA,et al.Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis[J].J Hepatol,1998,28(3):514-517.
|
|
[9]RIGOPOULOU EI,ZACHOU K,GATSELIS N,et al.Autoimmune hepatitis in patients with chronic HBV and HCV infections:patterns of clinical characteristics,disease progression and outcome[J].Ann Hepatol,2013,13(1):127-135.
|
|
[10]ACAY A,DEMIR K,ASIK G,et al.Assessment of the frequency of autoantibodies in chronic viral hepatitis[J].Pak J Med Sci,2015,31(1):150-154.
|
|
[11]CLIFFORD BD,DONAHUE D,SMITH L,et al.High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C[J].J Hepatol,1995,21(3):613-619.
|
|
[12]LI Y,XU X,LIU P,et al.Clinical significance of autoantibodies detection in patients with chronic hepatitis C[J].Chin Hepatol,2007,12(1):17-19.(in Chinese)李颖,徐鑫,刘沛,等.慢性丙型肝炎患者自身抗体检测的临床意义[J].肝脏,2007,12(1):17-19.
|
|
[13]ANTONACI S,GIANNELLI G,SIMONE B,et al.Syndrome of overlap:chronic hepatitis C/autoimmune hepatitis:fact or fancy?[J].Recenti Prog Med,2005,96(1):27-31.
|
|
[14]CHRETIEN P,CHOUSTERMAN M,ABD ALSAMAD I,et al.Nonorgan-specific autoantibodies in chronic hepatitis C patients:association with histological activityand fibrosis[J].J Autoimmun,2009,32(3-4):201-205.
|
|
[15]GATSELIS NK,GEORGIDOU SP,KOUKOULIS GK,et al.Clinical significan coforgan-andnon-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C[J].Aliment Pharmacol Ther,2006,24(11-12):1563-1573.
|
|
[16]LENZI M,BELLENTANI S,SACCOCCIO G,et al.Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population:a nested case-control study of the Dionysos cohort[J].Gut,1999,45(3):435-441.
|
|
[17]European Association for the Study of the Liver.Clinical practice guidlines:autoimmune hepatitis[J].J Hepatol,2015,63(4):971-1004.
|
|
[18]WANG XW,WANG JB,MENG XW.Comparison of the serum autoantibody levels in auto immune hepatitis and HCV infection with autoimmune phenomenon[J].Chin J Hepatol,2004,12(3):176-177.(in Chinese)王宵伟,王江滨,孟祥伟.自身免疫性肝炎与丙型肝炎伴自身免疫现象者抗体水平的比较及临床分析[J].中华肝脏病杂志,2004,12(3):176-177.
|
|
[19]KOGURE T,UENO Y,FUKUSHIMA K,et al.Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peginterferon-alpha 2b plus ribavirin treatment[J].World J Gastroenterol,2007,13(32):4394-4397.
|
|
[20]RATHI C,PIPALIYA N,CHOKSI D,et al.Autoimmune hepatitis triggered by treatment with pegylated interferonα-2a and ribavirin for chronic hepatitis C[J].ACG Case Rep J,2015,2(4):247-249.
|
|
[21]ZHANG LF,ZHENG SG,YAN YG.Analyzing of auto-antibodies in autoimmune and C virus hepatic diseases[J].Chin J Lab Diag,2009,13(9):1199-1201.(in Chinese)张利方,郑山根,阎有功.自身免疫性肝炎与丙型肝炎患者自身抗体特征分析[J].中国实验诊断学,2009,13(9):1199-1201.
|
|
[22]MANNS MP.Hepatitis C and autoimmune hepatitis[J].Hepatology,2000,31(3):811-812.
|
|
[23]BACH N,THUNG SN,SCHAFFNER F.The histological features of chronic hepatitis C and autoimmune chronic hepatitis:a comparative analysis[J].Hepatology,1992,15(4):572-577.
|
|
[24]Chinese Socity of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 updated[J].J Clin Hepatol,2015,31(12):1961-1979.(in Chinese)中华医学会肝病学会,中华医学会感染病学分会.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979.
|
|
[25]ALVAREZ F,BERG PA,BIANCHI FB,et al.International Autoimmune Hepatitis Group Report:review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol,1999,31(5):929-938.
|
|
[26]HENNES EM,ZENIYA M,CZAJA AJ,et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology,2008,48(1):169-176.
|
|
[27]SCHIANO TD,TE HS,THOMAS RM,et al.Results of steroidbased therapy for the hepatitis C-autoimmune hepatitis overlap syndrome[J].Am J Gastroenterol,2001,96(10):2984-2991.
|
|
[28]CZAJA AJ.Autoimmune hepatitis and viral infection[J].Gastroenterol Clin North Am,1994,23(3):547-566.
|
|
[29]PETERSEN-BENZ C,KASPER HU,DRIES V,et al.Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome[J].Clin Gastroenterol Hepatol,2004,2(5):440-443.
|
DownLoad: